HUO, Xiaochuan, Piers KLEIN, Drumm Brian RAYNALD, Yimin CHEN, Muhammad M QURESHI, Wouter J SCHONEWILLE, Xinfeng LIU, Wei HU, Xunming JI, Chuanhui LI, Yuyou ZHU, Mohamad ABDALKADER, Daniel STRBIAN, Urs FISCHER, Volker PUETZ, Fana ALEMSEGED, Hiroshi YAMAGAMI, Simona SACCO, Gustavo SAPOSNIK, Patrik MICHEL, Espen Saxhaug KRISTOFFERSEN, Petra ŠEDOVÁ, Robert MIKULÍK, James E SIEGLER, Kyriakos LOBOTESIS, Dylan ROI, Jelle DEMEESTERE, Hongxin HAN, Guangxiong YUAN, Mai Duy TON, Hui-Sheng CHEN, Qingwu YANG, Zhongming QIU, Sheila O. MARTINS, Georgios TSIVGOULIS, Gotz THOMALLA, Simon NAGEL, Bruce C. V. CAMPBELL, Tudor G. JOVIN, Raul G. NOGUEIRA, Jean RAYMOND, Soma BANERJEE, Thanh N. NGUYEN and Zhongrong MIAO. Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) survey. Journal of Stroke and Cerebrovascular Diseases. AMSTERDAM: ELSEVIER, vol. 31, No 11, p. 1-10. ISSN 1052-3057. doi:10.1016/j.jstrokecerebrovasdis.2022.106804. 2022.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) survey
Authors HUO, Xiaochuan (guarantor), Piers KLEIN, Drumm Brian RAYNALD, Yimin CHEN, Muhammad M QURESHI, Wouter J SCHONEWILLE, Xinfeng LIU, Wei HU, Xunming JI, Chuanhui LI, Yuyou ZHU, Mohamad ABDALKADER, Daniel STRBIAN, Urs FISCHER, Volker PUETZ, Fana ALEMSEGED, Hiroshi YAMAGAMI, Simona SACCO, Gustavo SAPOSNIK, Patrik MICHEL, Espen Saxhaug KRISTOFFERSEN, Petra ŠEDOVÁ (203 Czech Republic, belonging to the institution), Robert MIKULÍK (203 Czech Republic, belonging to the institution), James E SIEGLER, Kyriakos LOBOTESIS, Dylan ROI, Jelle DEMEESTERE, Hongxin HAN, Guangxiong YUAN, Mai Duy TON, Hui-Sheng CHEN, Qingwu YANG, Zhongming QIU, Sheila O. MARTINS, Georgios TSIVGOULIS, Gotz THOMALLA, Simon NAGEL, Bruce C. V. CAMPBELL, Tudor G. JOVIN, Raul G. NOGUEIRA, Jean RAYMOND, Soma BANERJEE, Thanh N. NGUYEN and Zhongrong MIAO.
Edition Journal of Stroke and Cerebrovascular Diseases, AMSTERDAM, ELSEVIER, 2022, 1052-3057.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.500
RIV identification code RIV/00216224:14110/22:00128744
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2022.106804
UT WoS 000933363500001
Keywords in English Basilar artery occlusion; Mechanical thrombectomy; Endovascular therapy; Intravenous thrombolysis
Tags 14110127, 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 10/3/2023 09:50.
Abstract
Introduction Uncertainty remains on the optimal management of basilar artery occlusion (BAO). Two large randomized controlled trials (RCTs) in 2019 and 2021 demonstrated neutral results with respect to the use of endovascular therapy (EVT) for BAO. This study aimed to understand regional variation in physicians' perceptions towards the treatment of BAO as stratified by physician respondents from China versus outside China, prior to the publication of studies demonstrating a benefit of EVT for BAO. Methods An international online survey was conducted of stroke neurologists and neurointerventionalists from January to March 2022. Survey questions evaluated physician opinions toward the use of EVT in BAO, as well as the clinical and imaging features underlying treatment decisions. Respondents were dichotomized as either from China or from other countries and differences between groups were analyzed. Results There were 1245 physician respondents across 73 countries of which 295 (23.7%) were from China. Compared to respondents from the rest of the world, respondents from China were more likely to be interventionalists (71.5% vs 35.0%; p < 0.0001). Overall, more than 95% of respondents believed that EVT was superior to medical therapy under certain circumstances. Chinese respondents were more likely to believe that further RCTs were necessary than respondents from other countries (93.6% vs 76.2%; p < 0.0001). Chinese respondents were more likely to use advanced imaging in later time windows and use a premorbid mRS threshold of ≤2 for BAO selection to EVT. Conclusion Most stroke physicians believe EVT is beneficial in selected patients with BAO. Clinical and imaging modality differences were observed in the selection criteria used for EVT. There was greater inclination to enroll all trial eligible patients in a BAO RCT by respondents from China as compared to other parts of the world.
PrintDisplayed: 29/3/2024 01:46